Should colchicine be considered in patients with ischemic heart disease and persistently elevated hsCRP despite statin and aspirin therapy and appropriate physical activity?

Would you favor the use of colchicine, ezetimibe, or PCSK9 inhibitors as adjuncts to guideline directed medical care in patients with stable ischemic heart disease with LDL levels that remain above goal and elevated hsCRP levels?

• I would consider adding colchicine to their regimen
• I would consider adding ezetimibe to their regimen
• I would consider adding a PCSK9 inhibitor to their regimen
• Other